Willow Biosciences (TSE:WLLW) Stock Price Down 12.5% – Should You Sell?

Willow Biosciences Inc. (TSE:WLLWGet Free Report)’s share price dropped 12.5% during trading on Thursday . The stock traded as low as C$0.04 and last traded at C$0.04. Approximately 112,000 shares traded hands during mid-day trading, a decline of 77% from the average daily volume of 493,814 shares. The stock had previously closed at C$0.04.

Willow Biosciences Stock Up 14.3 %

The company has a debt-to-equity ratio of 902.05, a current ratio of 0.80 and a quick ratio of 19.71. The stock has a market capitalization of C$5.79 million, a P/E ratio of -0.73 and a beta of 1.13. The firm has a 50-day simple moving average of C$0.05 and a 200 day simple moving average of C$0.07.

Willow Biosciences Company Profile

(Get Free Report)

Willow Biosciences Inc is a Canadian biotechnology company based in Calgary. It produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Geographically, it derives a majority of revenue from Canada.

Further Reading

Receive News & Ratings for Willow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Willow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.